ici 118551 has been researched along with sirolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bucci, M; Cantalupo, A; Cirino, G; Irace, C; Miniaci, MC; Santamaria, R; Scotto, P | 1 |
1 other study(ies) available for ici 118551 and sirolimus
Article | Year |
---|---|
CL316,243, a selective β3-adrenoceptor agonist, activates protein translation through mTOR/p70S6K signaling pathway in rat skeletal muscle cells.
Topics: Actins; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Antagonists; Androstadienes; Animals; Cells, Cultured; Dioxoles; Gene Expression; Muscle Fibers, Skeletal; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Propanolamines; Protein Biosynthesis; Rats; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Skeletal Muscle Myosins; TOR Serine-Threonine Kinases; Wortmannin | 2013 |